25935.0000 -130.00 (-0.50%)
NSE Sep 07, 2026 12:52 PM
Volume: 2,281
 

25935.00
-0.50%
ICICI Direct
New introduction tempo also maintained- Overall growth continues to be driven by legacy power brands (top 10 brands CAGR ~10% between January 23-26 despite slowdown in Mixtard and Novomix) and traction in few brands from the marketed portfolio. The company remains a standout performer among MNCs on the back of new products launch trajectory (+100 launches in the last 12 years and another 75 planned for the next 5 years) and performance consistency in most of the legacy brands. In FY25, the company introduced 7 new brands- Citrosoda UTI, Digene Insta,...
Abbott India Ltd. has an average target of 33052.25 from 4 brokers.
More from Abbott India Ltd.
All earning calls
Investor presentations from Abbott India Ltd.
All investor presentations